Effect of combination of extracts of ginseng and ginkgo biloba on neurotransmitters in whole brain of β-amyloid peptide1-40 treated rat

Chinese Pharmacological Bulletin

Volumn 22, Issue 6, 2006, Pages 747-750

  Cong, Wei Hong ^a   Liu, Jian Xun ^a   Xu, Li ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

Acetylcholine; Extract; Ginkgo biloba; Ginseng; Monoamines; amyloid peptide

Indexed keywords

5 HYDROXYINDOLE; ACETYLCHOLINE; AMYLOID BETA PROTEIN; BETA AMYLOID PEPTIDE [1-40]; DOPAMINE; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HOMOVANILLIC ACID; MONOAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME IMMOBILIZATION; ENZYME REACTOR; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; NEUROTRANSMISSION; NONHUMAN; RAT;

EID: 33747189243     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jung S S, Nalbantoglu J, Cashman N R. Alzheimers beta-amyloid precursor protein is expressed on the surface of immediately exvivo brain cell; a flow cytometric study[J]. J Neurosci Res, 1996, 46 (3):336.
2. Auld D S, Kar S, Quirion R. Beta-amyloid peptides as direct cholinergic neuromodulators: A missing link[J]. Trends Neurosci, 1998, 21(1):43-9.
3. Geula C, Wu C K, Saroff DM, et al. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity[J]. Nat Med, 1998, 4(7):827-31.
4. Collerton D. Cholinergic function and intellectual decline in Alzheimers disease[J]. Neuroscience, 1986, 19(1):1-28.
5. Sramek J J, Anand R, Wardle T S, et al. Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimers disease [J]. Life Sci, 1996, 58(15):1201-7.
6. Rogers S L, Farlow M R, Doody R S, et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimers disease[J]. Neurology, 1998, 50(1):136-45.
7. Burke W J, Li S W, Schmitt C A, et al. Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, inlocusceruleuscellbodies in Alzheimers disease: mechanism of neuron death[J]. Brain Res, 1999, 816 (2):633-9.
8. 2 receptors in Alzheimers disease with Parkinsonism but not Parkinsons or Alzheimers Disease[J]. Neuropsy Chopharmacology, 1998, 19(6):472-9.
9. DeFeudis F V, Drieu K. Ginkgo biloba extract (EGB761) and CNS functions: basic studies and clinical applications[J]. Durr Drug Targets, 2000, 1(1):25.
10. Decker M W, McGaugh T L. The role of interaction between cholinergic system and other neuromodulatory systems in learning and memory[J]. Synapse, 1991, 7(2):151.